JPH0640826B2 - Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid - Google Patents
Novel plasmid, method for constructing the same, and novel microorganism containing the plasmidInfo
- Publication number
- JPH0640826B2 JPH0640826B2 JP5097286A JP5097286A JPH0640826B2 JP H0640826 B2 JPH0640826 B2 JP H0640826B2 JP 5097286 A JP5097286 A JP 5097286A JP 5097286 A JP5097286 A JP 5097286A JP H0640826 B2 JPH0640826 B2 JP H0640826B2
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- cgtase
- dna
- bacillus
- bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1074—Cyclomaltodextrin glucanotransferase (2.4.1.19)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、新規なプラスミド、さらに詳しくは、CGTase
の菌体外生産に関与する遺伝情報を担うデオキシリボ核
酸(DNA)断片を組み込んだプラスミド、該プラスミドの
構築方法及び該プラスミドを含有する新規微生物に関す
る。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel plasmid, more specifically, CGTase.
The present invention relates to a plasmid incorporating a deoxyribonucleic acid (DNA) fragment that carries the genetic information involved in the extracellular production of the above, a method for constructing the plasmid, and a novel microorganism containing the plasmid.
シクロデキストリンは、6〜8ヶ又はそれ以上のぶどう
糖分子がα−1, 4結合で環状に結合した非還元性の物質
である。シクロデキストリンを生成する酵素であるCGTa
seは、EC2.4.1.16として転移酵素に分類され
る。従来このCGTaseは、バチルス属に属する菌種、例え
ばバチルス・マセランス(Bacillus macerans)、バチル
ス・サーキュランス(Bacillus circulans)、バチルス・
メガテリウム(Bacillus megaterium)、バチルス・ステ
アロサーモフィラス(Bacillus stearothermophilus)等
又は、クレブシラ属に属する菌種例えば、クレブシラ・
ニューモア(Klebsiella pneumoniae)等を pH中性ない
し弱酸性の適当な培地で好気的に培養して得る方法
〔「酵素ハンドブック」:赤堀四郎監修、朝倉書店刊
(昭和41年)及び「アミラーゼ」:中村道徳監修、学
会出版センター刊(昭和61年)等参照〕及びバチルス属
に属する好アルカリ性細菌をpHアルカリ性の適当な培
地に好気的に培養して得る方法〔Horikoshi,K.,Akiba,
T.;“Alkalophilic Microorganisms"、学会センター(1
982年)及び特公昭52−93号公報等参照〕があった。Cyclodextrin is a non-reducing substance in which 6 to 8 or more glucose molecules are cyclically linked by α-1,4 bonds. CGTa, an enzyme that produces cyclodextrin
se is classified as a transferase as EC 2.4.1.16. Conventionally, this CGTase is a bacterial species belonging to the genus Bacillus, for example, Bacillus macerans, Bacillus circulans, Bacillus
Megaterium (Bacillus megaterium), Bacillus stearothermophilus (Bacillus stearothermophilus), etc., or a bacterial species belonging to the Klebsiella genus, for example, Klebsiella
A method of aerobically culturing Newmore (Klebsiella pneumoniae) or the like in an appropriate medium having a neutral or weakly acidic pH ["Enzyme Handbook": supervised by Shiro Akahori, published by Asakura Shoten (Showa 41) and "Amylase": See Nakamura Michinori, Academic Society Publishing Center (1986) etc.) and a method of aerobically culturing an alkalophilic bacterium belonging to the genus Bacillus in a suitable pH alkaline medium [Horikoshi, K., Akiba,
T .; "Alkalophilic Microorganisms", Academic Center (1
982) and Japanese Patent Publication No. 52-93).
しかし、これらの微生物による酵素の醗酵生産は培養時
間が長く、スケールアップが難しく又酵素の生産量が微
量であり、分離精製が困難であった。一方遺伝子工学を
利用したCGTaseの生産に関する研究は、バチルス・マセ
ランス由来のCGTase をバチルス・ズブチリス(Bacillu
s subtilis)及びエシェリヒア・コリへクローニングし
た研究(高野敏称,山根國男他;昭和59年度第7回日本
分子生物学大会)及びバチルス・マセランス及びバチル
ス・ステアロサーモフィラス由来のCGTaseをバチルス・
ズブチリス及びエシェリヒア・コリへクローニングした
研究(久保田倫夫、辻阪好夫他;昭和60年度日本醗酵工
学大会)が既に発表されているが、バチルス属に属する
好アルカリ性細菌に由来するアルカリ性CGTaseのエシェ
リヒア・コリへのクローニングの研究は、見当たらな
い。更にCGTaseをエシェリヒア・コリ株ヘクローニング
した上記学会報告では形質転換したエシェリヒア・コリ
株が、培養上澄液に大量の酵素を生産するという事実は
示されておらず、形質転換株から産業的に酵素を得るに
は、培養後菌体を集菌し、一度菌体を超音波等の手段に
より破壊して菌体内酵素を分離精製する必要があり、そ
の場合には菌体に由来する細胞性の毒性物質や不溶性粒
子の存在が問題となるため食品・医療品用の酵素として
適さない。However, in the fermentation production of enzymes by these microorganisms, the culture time is long, scale-up is difficult, and the amount of enzyme production is very small, which makes separation and purification difficult. On the other hand, research on the production of CGTase using genetic engineering was carried out using Bacillus macerans-derived CGTase as Bacillus subtilis (Bacillus subtilis).
s subtilis) and Escherichia coli clones (Toshiya Takano, Kunio Yamane et al .; 7th Annual Meeting of the Molecular Biology of Japan, 1984) and Bacillus macerans and CGTase from Bacillus stearothermophilus
Studies on cloning into subtilis and Escherichia coli (Tomoo Kubota, Yoshio Tsujisaka et al .; Japan Fermentation Engineering Conference in 1985) have already been published. No studies of cloning into are found. Furthermore, the above-mentioned academic conference report in which CGTase was cloned into the Escherichia coli strain did not show the fact that the transformed Escherichia coli strain produced a large amount of the enzyme in the culture supernatant, and the transformed strain was industrially used. In order to obtain the enzyme, it is necessary to collect the bacterial cells after culturing, and once destroy the bacterial cells by means such as ultrasonic waves to separate and purify the intracellular enzyme. It is not suitable as an enzyme for foods and medical products because the presence of toxic substances and insoluble particles of the above becomes a problem.
本発明は、上記従来技術の問題点を解決する菌体外生産
能に関与する特定の遺伝情報を担うデオキシリボ核酸
(DNA)を組み込んだ新規プラスミド、及びその構築
方法並びに、該プラスミドによって形質転換した新規微
生物を提供することを目的とするものである。The present invention solves the above-mentioned problems of the prior art by incorporating a novel plasmid incorporating deoxyribonucleic acid (DNA) carrying specific genetic information involved in extracellular productivity, a method for constructing the same, and transformation with the plasmid. The purpose is to provide a novel microorganism.
プラスミドは、微生物の細胞内に見出される染色体外遺
伝子で近年、微生物の遺伝子組み換えの手段として利用
され、醗酵工業の分野の研究におけるその重要性は益々
増大して来ている。A plasmid is an extrachromosomal gene found in the cells of microorganisms, which has recently been used as a means for gene recombination of microorganisms, and its importance in research in the field of the fermentation industry has been increasing.
近年、アミノ酸やペプチドの例にみられるように、微生
物の生育に必要とする特定の要求性や代謝産物の生産能
に関与する遺伝情報を担うDNAを組み込んだプラスミ
ドについて研究がなされ、また若干のプラスミドが宿主
微生物に導入され、その形質転換株が得られている。In recent years, as shown in the examples of amino acids and peptides, studies have been conducted on plasmids incorporating DNA that carries the genetic information involved in the specific requirement for the growth of microorganisms and the ability to produce metabolites, and some The plasmid has been introduced into the host microorganism, and a transformant thereof has been obtained.
本発明者はバチルス(Bacillus)属に属する微生物の代
謝産物であるアルカリ性CGTaseの菌体外生産に関与する
遺伝情報を担うDNAを組み込んだ新規プラスミドを調
製することに成功し、更に前記プラスミドをエシェリヒ
ア・コリ(Escherichia coli)HB101 株に導入して新規
且つ有用な形質転換株、エシェリヒア・コリ(Escherich
ia coli)HB101(pTUE202)を得ることに成功して本発明を
完成するに至った。The present inventor succeeded in preparing a novel plasmid into which a DNA carrying genetic information involved in extracellular production of alkaline CGTase, which is a metabolite of a microorganism belonging to the genus Bacillus, was incorporated, and the plasmid was further transformed into Escherichia coli.・ Escherichia coli, a new and useful transformant introduced into HB101 strain, Escherichia coli (Escherichia coli)
We succeeded in obtaining ia coli) HB101 (pTUE202) and completed the present invention.
以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
本発明において用いられる宿主微生物は、エシェリヒア
属のプラスミドとして知られるコリシンE1因子等の、
培養された細胞内で増殖し得る形質をとるプラスミド
(ベクターDNA)に、外来の遺伝子DNAとしてバチ
ルス属に属する微生物、例えばバチルスsp.#1011
菌(微工研菌寄第8685号)から調製されたDNA断片を
組み込んだプラスミドを含有させ得る、エシェリヒア・
コリによって代表されるエシェリヒア属に属する微生物
である。The host microorganism used in the present invention is a colicin E 1 factor known as a plasmid of the genus Escherichia,
A plasmid (vector DNA) having a trait capable of growing in the cultured cells is added to a microorganism belonging to the genus Bacillus as an exogenous gene DNA, for example, Bacillus sp. # 1011
Escherichia, which can contain a plasmid into which a DNA fragment prepared from a bacterium (Microtech Lab. No. 8685) has been incorporated.
It is a microorganism belonging to the genus Escherichia represented by Escherichia coli.
本発明に使用される、アルカリ性CGTaseの菌体外生産に
関与する遺伝情報を担うDNAを含有する微生物の例と
しては、バチルスsp.#1011菌(微工研菌寄第8685
号)をあげることができる。バチルスsp.#1011菌
は静岡県袋井市で採取された土壌より分離された微生物
であり、次の菌学的性質を有する。なお、菌学的性質の
試験及び分類方法は、「エアロビック・スポアホーミン
グ・バクテリア」〔“Aerobic Sporeforming Bacteri
a”(United State Department of Agriculture,Nov.195
2 by N.R.Smith,R.E.Gordon &F. E. Clark)〕及び「バ
ージェーズ・マニュアル・オブ・デタミネイティブ・バ
クテリオロジー」〔“Bergry′s Manual of Daterminat
ive Bacteriology"(1957 )〕に基づいて行われた。Examples of the microorganisms used in the present invention, which contain DNA carrying the genetic information involved in the extracellular production of alkaline CGTase, include Bacillus sp. # 1011 bacterium
No.) can be given. Bacillus sp. The # 1011 bacterium is a microorganism isolated from soil collected in Fukuroi City, Shizuoka Prefecture, and has the following mycological properties. In addition, the test and classification method of the mycological properties are described in “Aerobic Sporeforming Bacteri”.
a ”(United State Department of Agriculture, Nov.195
2 by NRSmith, REGordon & F.E. Clark)] and "Bergese's Manual of Determinative Bacteriology"["Bergry's Manual of Daterminat
ive Bacteriology "(1957)].
(バチルスsp.#1011菌の菌学的性質) イ.形態 1当たりデンプン15g、ポリペプトン10g、イースト
エキス5g、K2HPO41g、MgSO4・7H2O 0.2g、炭酸
ナトリウム10g、寒天15gを含む組成(pH10.0)の平板
寒天培地上で(但し、炭酸ナトリウムは、他の成分と別
にオートクレーブし、その後培地に加える。)、観察さ
れる形態を表1に示す。(Mycological Properties of Bacillus sp. # 1011 B) Form 1 On a plate agar medium having a composition (pH 10.0) containing 15 g of starch, 10 g of polypeptone, 5 g of yeast extract, 1 g of K 2 HPO 4 , 0.2 g of MgSO 4 .7H 2 O, 10 g of sodium carbonate and 15 g of agar per form 1 ( However, sodium carbonate is autoclaved separately from other components and then added to the medium.), And the observed morphology is shown in Table 1.
ロ.生育状態 #1011菌の各種培地における生育状態を表2に示す なお、培地 pH7.0 ではほとんど生育せず、変化が認め
られなかったので、培地にそれぞれ炭酸ナトリウムを1
%加えて pH10.0とした。 B. Growth condition Table 2 shows the growth condition of the # 1011 bacteria in various media. In addition, since there was almost no growth in the media pH 7.0 and no change was observed, 1% sodium carbonate was added to the media.
% To make pH 10.0.
ハ.生理的性質 #1011菌に関し、生理試験用培地にそれぞれ炭酸ナ
トリウムを1%加えて試験した結果を表3-1 〜3-2 に示
す。 C. Physiological Properties Tables 3-1 and 3-2 show the results of the test on the # 1011 bacteria by adding 1% of sodium carbonate to each of the physiological test media.
バチルスsp.#1011菌は、上記の菌学的諸性質を総
括すると、好気性の有胞子細菌であることから、バチル
ス(Bacillus)属に属する微生物であることは明らかで
あるが、特に生育し得る範囲がpH8〜12である点にお
いて明らかに公知の菌種と区別され、好アルカリ性菌体
の新菌種と認定することが妥当であると結論された。 Bacillus sp. The # 1011 bacterium is an aerobic spore bacterium when the above-mentioned various bacteriological properties are summarized. Therefore, it is clear that the # 1011 bacterium is a microorganism belonging to the genus Bacillus. It was clearly distinguished from known bacterial species in that the pH was 8 to 12, and it was concluded that it is appropriate to identify it as a new bacterial species of alkalophilic cells.
前記ベクターDNAに組み込まれる。バチルスsp.#1
011菌から調製されたDNA断片は、前記バチルス属
細菌の代謝産物であるCGTaseの菌体外生産に関与する遺
伝情報を担うDNAであり、前記ベクターDNAとして
は、天然に存在するものを抽出したものの他、増殖に必
要な部分以外のDNAの部分が一部欠落しているもので
もよく、例えばColE1の系統、pMB9の系統、pBR322の系
統、pSC101の系統等が挙げられる。It is incorporated into the vector DNA. Bacillus sp. # 1
The DNA fragment prepared from 011 bacterium is a DNA that carries the genetic information involved in the extracellular production of CGTase, which is a metabolite of the Bacillus bacterium, and the naturally-occurring vector DNA was extracted. In addition to the above, a part of DNA other than the part necessary for proliferation may be partially deleted, and examples thereof include ColE 1 strain, pMB9 strain, pBR322 strain, pSC101 strain and the like.
また、前記のベクターDNAに前記DNA断片を組み込
む方法は、既知のいずれの方法も適用し得る。例えば、
適当な制限酵素(Endonuclease)を選択、処理してDN
A特定部位で切断し、次いで相補的な塩基配列を切断部
位に形成する制限酵素で処理したベクターDNAを混合
し、リガーゼによって再結合する方法が用いられる。こ
のようにして得られた前記DNA断片とベクターDNA
の結合物を、形質転換法によって受容菌であるエシェリ
ヒア属の微生物の菌体に導入し、遺伝形質として安定す
るまで増殖すると、所望の遺伝形質とベクターDNAの
形質を併せもつ形質転換株が得られる。Further, as a method for incorporating the DNA fragment into the vector DNA, any known method can be applied. For example,
Select and treat appropriate restriction enzyme (Endonuclease)
A method is used in which the vector DNA cleaved at the A specific site, then treated with a restriction enzyme that forms a complementary nucleotide sequence at the cleavage site, is mixed and religated with ligase. The DNA fragment and the vector DNA thus obtained
The ligation product of E. coli is introduced into the cells of the recipient microorganism Escherichia by the transformation method and propagated until it becomes stable as a genetic trait, whereby a transformant having both the desired genetic trait and the vector DNA trait is obtained. To be
後述の実施例において得られる形質転換株は、次の2段
階の操作により創製される。但し、の操作は省略可能
で、バチルスsp.#1011菌から調製されたDNA断
片を直接pBR322等のベクターDNAへ組み込んで行うこ
とも可能である。The transformants obtained in the examples described below are created by the following two-step operation. However, the operation of is optional. It is also possible to directly incorporate the DNA fragment prepared from the # 1011 bacterium into vector DNA such as pBR322.
バクテリオファージベクターDNAとしてλD69ファ
ージのDNA〔 Silhavy T.J., Berman M.L.,Enquist
L.W.:Experiments with Gene Fusions "(Cold Spring
Harbar Laboratory (1984)p. 247参照,これは制限 end
onuclease BamHI による切断サイトを1ヶ所持つ 38.8k
b のDNAである。制限酵素切断地図を第4図に示
す。〕を用い、これにバチルスsp.#1011菌から調
製されたDNA断片を組み込んでイン・ビトロ・パッケ
ージング法〔(Horn,B.,Murray,K.:Proc.Natl.Acad.Sci.
U.S., 74.3259 (1977)〕により得られた新規形質導入フ
ァージ粒子λD69-TU110を調製する。DNA of λD69 phage as a bacteriophage vector DNA [Silhavy TJ, Berman ML, Enquist
LW: Experiments with Gene Fusions "(Cold Spring
See Harbar Laboratory (1984) p. 247, which is a restriction end
38.8k with one cleavage site by onuclease BamHI
It is the DNA of b. A restriction enzyme digestion map is shown in FIG. ], And the Bacillus sp. In vitro packaging method [(Horn, B., Murray, K.:Proc.Natl.Acad.Sci.
US, 74 .3259 (1977)] to prepare a new transducing phage particles λD69-TU110 obtained by.
プラスミドベクターDNAとしてpBR322を用い、これ
に前記形質導入ファージ粒子から調製されたDNA断片
を組み込んで得られた新規pTUE202 プラスミドを、エシ
ェリヒア・コリHB101 株(エシェリヒア・コリ12株と
エシェリヒア・コリB株のハイブリッド株)に導入して
形質転換反応により新規微生物を創製し、これはエシェ
リヒア・コリHB 101(pHUE 202)〔Escherichia coli H
B101 (pTUE 202)〕と呼称される。前記エシェリヒア・
コリHB101(pTUE 202)のpTUE202 プラスミドの制限酵
素切断地図は、第3図に示すとおりである。Using pBR322 as the plasmid vector DNA, the novel pTUE202 plasmid obtained by incorporating the DNA fragment prepared from the above-mentioned transducing phage particles into Escherichia coli HB101 strain (Escherichia coli 12 strain and Escherichia coli B strain (Hybrid strain) and a transformation reaction to create a new microorganism, which is Escherichia coli HB 101 (pHUE 202) [Escherichia coli H
B101 (pTUE 202)]. Said Escherichia
The restriction enzyme digestion map of the pTUE202 plasmid of E. coli HB101 (pTUE202) is shown in FIG.
第3図から明らかなように、このプラスミドは、pBR322
プラスミドDNAの制限サイトのBamHIサイトに前記バ
チルスsp.#1011菌のアルカリ性CGTaseの菌体外生
産に関与する遺伝情報を担うアルカリ性CGTaseDNA断
片が組み込まれているDNA円形分子であり、即ちpBR3
22プラスミドDNAと約4,700 の塩基対のDNAから成
る9.1Kb の新規なDNA円形分子である。As is clear from FIG. 3, this plasmid is pBR322.
At the BamHI site of the restriction site of the plasmid DNA, the Bacillus sp. # 1011 is a circular DNA molecule incorporating an alkaline CGTase DNA fragment, which carries the genetic information involved in extracellular production of alkaline CGTase, namely pBR3
It is a novel circular DNA molecule of 9.1 Kb consisting of 22 plasmid DNA and DNA of about 4,700 base pairs.
次に、前記エシェリヒア・コリHB 101 (pTUE 202)の
菌学的性質は、DNA受容菌であるエシェリヒア・コリ
HB 101株の性質と、アンピシン耐性、アルカリ性CGTa
se生産性を除いて、同一であるが〔Molecular Cloning
A Laboratory Manual ,p. 504 (1982)参照、遺伝形質:
F-hsdS20(r ,m ),rec A13,ara-14,proA2, lacY
1, galK2,rpsL20(Smr),xyl-5,mtl-1,supE44, λ-〕、他
の特性として、pTUE 202プラスミドの特性、即ちアルカ
リ性CGTase生産能の遺伝情報を担うpTUE202 プラスミド
によってCGTaseを菌体外に生産し、蓄積せしめる特性を
附加して成る点がその特徴である。Next, the Escherichia coli HB 101 (pTUE 202)
Mycologically, Escherichia coli, which is a DNA recipient,
Properties of HB 101 strain, ampicin resistance, alkaline CGTa
Same except for se productivity, but [Molecular Cloning
See A Laboratory Manual, p. 504 (1982), Genetic traits:
F-hsdS20 (r , M ), Rec A13, ara-14, proA2, lacY
1, galK2, rpsL20 (Smr), xyl-5, mtl-1, supE44, λ-〕,other
As a characteristic of pTUE 202 plasmid,
PTUE202 plasmid that carries the genetic information of the ability to produce soluble CGTase
Has the property of producing CGTase extracellularly and accumulating it.
The feature is that it is added.
エシェリヒア・コリHB 101 (pHUE 202)によるアルカ
リ性CGTaseの菌体外生産は、後述の実施例で示されるよ
うに、培養開始後約12時間で認められ、且つ時間その生
産量が持続される(第1図参照)これに対し、前記バチ
ルスsp.#1011菌によるアルカリ性CGTaseの菌対外
生産は、第2図に示すように、培養開始3日後に最高に
達する。従って、本発明は、前記エシェリヒア・コリH
B 101 (pTUE 202)、すなわち、従来皆無であった酵素
蛋白の菌体外生産能を有し且つ、CGTaseを極めて有利に
生産し得る微生物を創製、提供する点において、新規性
と有用性を具備するものである。The extracellular production of alkaline CGTase by Escherichia coli HB 101 (pHUE 202) was observed about 12 hours after the start of the culture, and the production amount was maintained for a time (see Example 1). On the other hand, the Bacillus sp. As shown in FIG. 2, the extracellular production of alkaline CGTase by the # 1011 bacterium reaches a maximum after 3 days from the start of culture. Therefore, the present invention relates to the above Escherichia coli H.
B 101 (pTUE 202), that is, novel and useful in terms of creating and providing a microorganism which has the ability to produce an enzyme protein extracellularly, which has been heretofore none, and which can produce CGTase extremely advantageously It is equipped with.
これは、本発明によって得られるpTUE 202プラスミドに
含まれる約4,700 の塩基対のDNAが、代謝産物の菌体
外生産能を宿主に付与していることを意味するものであ
る。This means that the DNA of about 4,700 base pairs contained in the pTUE 202 plasmid obtained by the present invention imparts the extracellular productivity of metabolites to the host.
以下に、本発明のプラスミドの構築方法と該プラスミド
を含有する前記形質転換株、エシェリヒア・コリHB 1
01(pTUE 202)の製方法並びに前記形質転換株による効
果について、実施例により説明する。The method for constructing the plasmid of the present invention and the transformant containing the plasmid, Escherichia coli HB 1 are described below.
The method for producing 01 (pTUE 202) and the effect of the transformant will be described with reference to Examples.
実施例 〔実施例 1〕 (1)アルカリ性CGTase生産能の遺伝情報をもつ染色体D
NAの調製 アルカリ性CGTaseを菌体外に生成、蓄積する能力を有す
る好アルカリ性のバチルスsp.#1011菌(微工研菌
寄第8685号)を培地〔1当りデンプン15g、ペプトン
10g、イーストエキス5g、K2HPO41g、MgSO4・7H2O
0.2gを含み炭酸ナトリウム10gでpH10.0に調整し
た組成〕中、40℃で12時間振盪培養を行い、対数増殖後
期の菌体を集菌後、Saito, Miura法(Saito, H.,Miura,
K.:Biochem.Biophys. Acta,72,619,(1964))によるD
NA抽出法によってDNAを抽出、精製し、染色体DN
A約5mgを得た。Example [Example 1] (1) Chromosome D having genetic information of alkaline CGTase-producing ability
Preparation of NA An alkalophilic Bacillus sp. Which has the ability to produce and accumulate alkaline CGTase outside the cells. # 1011 bacterium (Microtech Lab. No. 8685) was used as a medium [15 g starch per 1 part, peptone
10g, yeast extract 5g, K 2 HPO 4 1g, MgSO 4 · 7H 2 O
In a composition containing 0.2 g of sodium carbonate and adjusted to pH 10.0 with 10 g of sodium carbonate), shake culture was carried out at 40 ° C. for 12 hours, and cells in the late logarithmic growth phase were collected, and then the Saito, Miura method (Saito, H., Miura,
K .: Biochem. Biophys. Acta, 72 , 619, (1964)) D
DNA extraction and purification by NA extraction method
A about 5 mg was obtained.
(2)染色体DNA断片のファージDNAへの挿入 前記(1)で得た染色体DNA300μgをとり、制限エンド
ヌクレアーゼSau3AI(宝酒造(株)製)を加え、0℃で30
分反応させて部分的に切断した。更に、蔗糖密度勾配超
遠心法にて、約7〜12Kbの染色体DNA断片を分離精製
してDNA断片を調製した。バクテリオファージλD
69のDNA(東京大学医科学研究所より分譲)20μgを
制限エンドヌクレアーゼBamHI(宝酒造(株)製)で完全に
分解してその一部と、前記DNA断片を混合しT4フ
ァージ由来のDNAリガーゼ(宝酒造(株)製)によって
10℃、24時間DNA鎖の連結反応を行い、イン・ビトロ
・パッケージング・キット(Amersham International社
製)を使用して、形質導入ファージ粒子とした。1%デ
ンプンを含むλ培地〔1当りバクトトリプトン(Difc
o)10g、NaCl2.5gを含む組成〕寒天平板上にエシェ
リヒア・コリSM32株(東京大学医科学研究所により分
譲,遺伝形質:SA500, his,pyrD,lons 100, gal,str
A)を37℃にて生育させ、これに前記形質導入ファージ
粒子を感染させて得た多数のプラーク(溶菌斑)の中か
らアルカリ性CGTase活性を有する形質導入ファージλD
69-TU110粒子を得た。1のλ培地でエシェリヒア・コ
リSM32株とともにこの形質導入ファージ粒子を培養し
た後 PEG6000法〔K.R.Yamamoto,B.M alberto,R.Benzing
er,L,Low horne & G.Treiber:Virolgy, 4
0,734 (1970)〕により形質導入ファージD
NAを抽出、精製し約50KbのDNAを約150μg得た。(2) Insertion of chromosomal DNA fragment into phage DNA 300 μg of chromosomal DNA obtained in (1) above was taken, restriction endonuclease Sau3AI (Takara Shuzo Co., Ltd.) was added, and the mixture was incubated at 0 ° C. for 30 minutes.
It was allowed to react for minutes and partially cut. Furthermore, a chromosomal DNA fragment of about 7 to 12 Kb was separated and purified by a sucrose density gradient ultracentrifugation method to prepare a DNA fragment. Bacteriophage λD
20 μg of 69 DNA (sold from the Institute of Medical Science, The University of Tokyo) was completely digested with the restriction endonuclease BamHI (Takara Shuzo Co., Ltd.) and a part of the digested DNA fragment was mixed with the DNA fragment of T4 phage ( Takara Shuzo Co., Ltd.)
The DNA strands were ligated at 10 ° C. for 24 hours, and used as transducing phage particles using an in vitro packaging kit (manufactured by Amersham International). Lambda medium containing 1% starch [per bactotryptone (Difc
o) Composition containing 10 g and NaCl 2.5 g] Escherichia coli SM32 strain (sold by the Institute of Medical Science, University of Tokyo, genetic trait: SA500, his, pyrD, lons 100, gal, str) on an agar plate
A) was grown at 37 ° C., and transduced phage λD having alkaline CGTase activity was selected from a large number of plaques obtained by infecting the same with the above-mentioned transduced phage particles.
69-TU110 particles were obtained. After culturing this transducing phage particle with the Escherichia coli SM32 strain in the λ medium of 1, the PEG6000 method [KRYamamoto, BM alberto, R. Benzing
er, L, Low horne & G. Treiber: Virology, 4
0, 734 transducing phage D by (1970)]
NA was extracted and purified to obtain about 150 μg of about 50 Kb DNA.
(3)形質導入ファージDNA断片のプラスミドベクター
への挿入 前記(2)で得たDNA50μgをとり、Sau3AIを加え、0
℃で30分反応させて部分的に切断した。更に蔗糖密度勾
配超遠心法にて約2〜9Kbの形質導入ファージDNA
断片を分離精製してDNA断片を調製した。一方プラ
スミドベクターとして用いられるテトラサイクリン抵抗
性(Tetr)とアンピシリン抵抗性(Ampr)をもつpBR322
プラスミドDNA(Bethesda Research Laboratories 社
(米国)製)をBam H I で完全に分解して65℃、10分の
熱処理をしてBAP(;Bacterial Alkaline Phosphatase)
処理後前記DNA断片と混合し、T4DNAリガーゼ
によって10℃、24時間DNA鎖の連結反応を行い、DN
A断片を組み込んだプラスミドDNAを構築した。(3) Insertion of the transduced phage DNA fragment into a plasmid vector Take 50 μg of the DNA obtained in (2) above, add Sau3AI,
The mixture was reacted at 30 ° C. for 30 minutes and partially cut. Furthermore, a transducing phage DNA of about 2 to 9 Kb by sucrose density gradient ultracentrifugation
The fragment was separated and purified to prepare a DNA fragment. On the other hand, pBR322 with tetracycline resistance (Tet r ) and ampicillin resistance (Amp r ) used as a plasmid vector
Plasmid DNA (manufactured by Bethesda Research Laboratories (USA)) was completely digested with Bam HI and heat-treated at 65 ° C for 10 minutes to obtain BAP (; Bacterial Alkaline Phosphatase).
After the treatment, it is mixed with the above DNA fragment, and the DNA chain is ligated with T4 DNA ligase at 10 ° C. for 24 hours to give DN.
A plasmid DNA incorporating the A fragment was constructed.
(4)アルカリ性CGTaseの菌体外生産遺伝子を担うプラス
ミドによる形質転換 エシェリヒア・コリK−12株とエシェリヒア・コリB株
のハイブリッド株であるエシェリヒア・コリHB 101株
をL培地(1当たりトリプトン(Difco )10g、イース
トエキス(Difco)5g、NaCl 5gを含み、pH 7.0に調整し
たもの)50 mlに接種し、37℃で振盪培養を行い、対
数増殖後期まで生育させた後に集菌した。これを氷冷
下、最終濃度で0.1M CaCl2の溶液に順次懸濁させてコン
ピテントな細胞とした。この細胞懸濁液に(3)で得たプ
ラスミドDNAの溶液を加えて氷冷下で30分反応させ、
42℃、2分間、ヒートショックを与えて前記プラスミ
ドDNAを細胞内に取り込ませた。次いで、この細胞懸
濁液を別途、前記L培地に接種し、37℃、60分間振盪培
養して形質転換反応〔Lederberg, E.M.,Cohen,S.N.;J.
Bacteriol.119, 1072(1974)〕を行って、得られた形質
転換株をLSAmp 寒天平板(1当りトリプトン(Difco)10
g, イーストエキス(Difco)5g,デンプン10g,NaCl5g,アン
ピシリン50mg,寒天15g の組成)上で37℃にて培養し、
アンピシリン耐性で且つアルカリ性CGTase活性を有する
エシェリヒア・コリHB 101(pTUE 202)を得た。(4) Transformation with a plasmid carrying the extracellular production gene of alkaline CGTase Escherichia coli HB 101 strain, which is a hybrid strain of Escherichia coli K-12 strain and Escherichia coli B strain, was mixed with L medium (tryptone (Difco ) 10 g, yeast extract (Difco) 5 g, and NaCl 5 g and adjusted to pH 7.0) 50 ml), inoculated with shaking culture at 37 ° C., grown to the late logarithmic growth phase, and then collected. This was sequentially suspended in a solution of 0.1 M CaCl 2 at a final concentration under ice cooling to obtain competent cells. The plasmid DNA solution obtained in (3) was added to this cell suspension, and the mixture was reacted under ice cooling for 30 minutes,
The plasmid DNA was incorporated into the cells by heat shock at 42 ° C. for 2 minutes. Then, this cell suspension was separately inoculated into the L medium, shake-cultured at 37 ° C. for 60 minutes, and the transformation reaction [Lederberg, EM, Cohen, SN; J.
Bacteriol. 119, 1072 (1974)], and the resulting transformants were subjected to LSAmp agar plates (tryptone (Difco) 10 per plate).
g, yeast extract (Difco) 5 g, starch 10 g, NaCl 5 g, ampicillin 50 mg, agar 15 g) at 37 ° C.,
Escherichia coli HB 101 (pTUE 202) having ampicillin resistance and alkaline CGTase activity was obtained.
〔実施例 2〕 実施例1の(4)で得られた形質転換株、エシェリヒア・
コリHB 101 (pTUE 202)をLAmp培地〔1当たりトリ
プシン(Difco) 10g 、イーストエキス(Difco) 5g、 NaCl
5g 、アンピシリン50mgを含む組成〕100 mlを含む500
ml容坂口フラスコで37℃にて振盪培養した。細胞の生育
(菌体量)は660nmの吸光度(OD)で、測定した。アルカリ
性CGTaseの酵素活性は、酵素液0.05 mlにM/10グリ
シン-NaCl 緩衝液(pH10.5)に溶解した1%可溶性デン
プン液0.5mlを加えて40℃にて2時間反応した後、酢
酸でpHをK性にし、100 ℃で10分間加熱した。これに50
μgのグルコアミラーゼを加えて、40℃で1時間未反応
のデンプンを分解した後、生じたグルコースの量をジニ
トロサリチル酸法で測定した。また、対照として酵素液
のかわりに水を加えたものを上記と全く同様に処理し、
この両者の差をもってシクロデキストリンの生成量とし
た。ここで1単位とは上記の方法で1mg のシクロデキス
トリンを生成する酵素量をいう(特公昭52−93号公報参
照)。[Example 2] The transformant obtained in Example 1 (4), Escherichia
E. coli HB 101 (pTUE 202) was added to LAmp medium [10 g of trypsin (Difco), 5 g of yeast extract (Difco), NaCl per 1 ml].
Composition containing 5 g and 50 mg ampicillin] 500 containing 100 ml
The culture was carried out at 37 ° C. with shaking in a ml volume Sakaguchi flask. Cell growth
(Amount of cells) was measured by the absorbance (OD) at 660 nm. The enzymatic activity of alkaline CGTase was determined by adding 0.5 ml of 1% soluble starch solution dissolved in M / 10 glycine-NaCl buffer (pH 10.5) to 0.05 ml of enzyme solution and reacting at 40 ° C for 2 hours. The pH was brought to K and heated at 100 ° C for 10 minutes. 50 to this
After the unreacted starch was decomposed at 40 ° C. for 1 hour by adding μg of glucoamylase, the amount of glucose produced was measured by the dinitrosalicylic acid method. Also, as a control, water was added instead of the enzyme solution and treated in exactly the same manner as above,
The difference between the two was used as the amount of cyclodextrin produced. Here, 1 unit means the amount of enzyme that produces 1 mg of cyclodextrin by the above method (see Japanese Patent Publication No. 52-93).
形質転換株の菌体量は培養開始後12時間で最大に達し
(第1 図に示す)、菌体外アルカリ性CGTase の活性
は、ほぼ24時間で最大に達した。生産されたアルカリ性
CGTaseは非常に安定である。The amount of bacterial cells in the transformant reached a maximum 12 hours after the start of culture (shown in Fig. 1), and the extracellular alkaline CGTase activity reached a maximum in approximately 24 hours. Produced alkaline
CGTase is very stable.
比較として、DNA供与菌である前記好アルカリ性バチ
ルスsp.#1011菌(微工研菌寄第8685号)を培養し
て、アルカリ性CGTase活性を測定した。1当たりデン
プン 15g、ポリペプトン10g、イーストエキス 5g、H2HP
o41g、MgSO4・7H2O 0.2g、炭酸ナトリウム10g を含む
培地(pH10.0)に接種し、40℃にて振盪培養した。As a comparison, the alkalophilic Bacillus sp. The # 1011 bacterium (Microtechnology Research Institute, No. 8685) was cultured and the alkaline CGTase activity was measured. 15g starch, 10g polypeptone, 5g yeast extract, H 2 HP
o 4 1 g, was inoculated into the medium (pH 10.0) containing MgSO 4 · 7H 2 O 0.2g, sodium carbonate 10 g, and cultured with shaking at 40 ° C..
菌体量は培養開始後24時間で最大に達し、(第2図に示
す)菌体外アルカリ性CGTaseの活性は、接種後24時間で
徐々に活性が上がり、72時間に至ってやっと活性は最高
に達した。The amount of bacterial cells reached the maximum 24 hours after the start of the culture, and the activity of extracellular alkaline CGTase (shown in Fig. 2) gradually increased 24 hours after the inoculation, and reached the maximum at 72 hours. Reached
〔実施例 3〕 形質転換株、エシェリヒア・コリHB101 (pTUE 202)を実
施例2と同様な操作にて培養開始後24時間の培養液を
遠心分離し、除菌して調整した培養澄液100 mlに硫酸ア
ンモニウムを加えて塩析した後、沈澱を水に溶かして一
夜流水で透析し、アルカリ性CGTase酵素液とした。フラ
スコにN/10グリシン-NaCl 緩衝液にてpH10.5に調製し
た 5%のデンプン糊化液(CaCl2を10mM含む)1を入
れ、上記酵素液25ml加えて65℃にて6 時間酵素反応し
た。反応終了後遠心分離して沈澱物を除き、トリクロル
エチレンを加えて生成物を沈澱させ、沈澱物を水で洗條
後、トリクロルエチレンを加熱して除き、60%プロピル
アルコール水溶液から再結晶して白色の結晶約18gを得
た。アビセル薄層クロマトグラフィーにより前記結晶を
分析したところ、n−ブタノール:プロパノール:水
(3:5:4)の展開液で2回上昇法にて分離した後1
%ヨウ素メタノール溶液を雰霧して、試薬のRf値と一致
するα−及びβ−シクロデキストリン特有の呈色を示す
スポットを認めた。[Example 3] The transformant Escherichia coli HB101 (pTUE 202) was subjected to the same operation as in Example 2 by centrifuging a culture solution for 24 hours after the start of culture to remove the bacteria to prepare a culture supernatant 100. After ammonium sulfate was added to ml for salting out, the precipitate was dissolved in water and dialyzed against running water overnight to obtain an alkaline CGTase enzyme solution. Add 5% starch gelatinization solution (containing 10 mM CaCl 2 ) 1 adjusted to pH 10.5 with N / 10 glycine-NaCl buffer solution to the flask, add 25 ml of the above enzyme solution, and perform an enzyme reaction at 65 ° C for 6 hours. did. After completion of the reaction, the precipitate was removed by centrifugation to remove the precipitate, and the product was precipitated by adding trichlorethylene. After washing the precipitate with water, the trichlorethylene was heated to remove, and recrystallized from a 60% propyl alcohol aqueous solution. About 18 g of white crystals were obtained. When the crystals were analyzed by Avicel thin layer chromatography, they were separated with a developing solution of n-butanol: propanol: water (3: 5: 4) by the ascending method twice and then 1
A% iodine methanol solution was atomized, and spots showing a color peculiar to α- and β-cyclodextrin corresponding to the Rf value of the reagent were observed.
更に高速液体クロマトグラフィーによりシリカ系ODS-NH
2樹脂を充填したカラム(8φ×250 mm)を使用し、ア
セトニトリル:水(65:35)の溶離液にて分離し示差屈
折計で検出したところ試薬のα−,β−及びγ−シクロ
デキストリンのリテンションタイムと一致して生成物を
同定した。Silica-based ODS-NH by high performance liquid chromatography
2 Using a column packed with resin (8φ x 250 mm), separating with an eluent of acetonitrile: water (65:35) and detecting with a differential refractometer, the reagents α-, β- and γ-cyclodextrin The product was identified according to the retention time of.
本発明のCGTaseの菌体外生産に関与する遺伝情報を担う
DNA断片を組み込んだプラスミドは、これを遺伝子工
学的手法によりエシェリヒア属に属する微生物に含有さ
せて形質転換させることにより、短い培養時間でCGTase
を生産するエシェリヒア属に属する新規微生物を創製す
ることができ、しかも前記微生物はCGTaseを菌体外に大
量に生産するので、この微生物を使用することにより、
工業的かつ効率的に大量のCGTaseを生産することが可能
となった。The plasmid in which the DNA fragment carrying the genetic information involved in the extracellular production of CGTase of the present invention is incorporated into a microorganism belonging to the genus Escherichia by a genetic engineering technique and transformed, so that the culture time can be shortened. CGTase
It is possible to create a new microorganism belonging to the genus Escherichia that produces, and since the microorganism produces a large amount of CGTase outside the cells, by using this microorganism,
It has become possible to industrially and efficiently produce a large amount of CGTase.
第1図は、本発明方法で用いたエシェリヒア・コリHB
101 (pTUE 202)による菌体外アルカリ性CGTase生産活
性を、第2図は、バチルスsp.#1011菌による菌体
外アルカリ性CGTase生産活性をそれぞれ示すグラフであ
る。第3図は、エシェリヒア・コリHB 101 (pTUE 20
2)のプラスミド(pTUE 202)の制限酵素切断地図であ
り、白ぬきの部分はpBR322プラスミドDNA由来、黒塗
りの部分はバチルスsp.#1011菌染色体DNA断片
(アルカリ性CGTaseDNA断片)を示す。 第4図は、バクテリオファージλD69の制限酵素切断地
図である。FIG. 1 shows Escherichia coli HB used in the method of the present invention.
Fig. 2 shows the extracellular alkaline CGTase production activity of 101 (pTUE 202) as shown in Bacillus sp. 2 is a graph showing extracellular alkaline CGTase production activity by # 1011 bacterium. Figure 3 shows Escherichia coli HB 101 (pTUE 20
It is a restriction enzyme digestion map of the plasmid (pTUE 202) of 2), the open part is derived from pBR322 plasmid DNA, and the black part is Bacillus sp. # 1011 chromosomal DNA fragment (alkaline CGTase DNA fragment) is shown. FIG. 4 is a restriction enzyme digestion map of bacteriophage λD69.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:07) (C12N 1/21 C12R 1:19) (C12N 9/10 C12R 1:19) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location C12R 1:07) (C12N 1/21 C12R 1:19) (C12N 9/10 C12R 1:19)
Claims (17)
に菌体外生産能を与えるプラスミドであって、バチルス
(Bacillus)属に属する微生物のシクロマルトデキストリ
ン グルカノトランスフェラーゼ(Cyclomaltodextrin g
lucanotransferase,以下、CGTaseという。)の菌体外生
産に関与する遺伝情報を担い、下記の制限酵素地図を有
するバチルスsp.#1011菌(微工研菌寄第868
5号)由来のデオキシリボ核酸(DNA)断片をその制
限サイトに組み込んだプラスミド。 1. A plasmid which gives extracellular ability to a host belonging to the genus Escherihia, which is Bacillus
Cyclomaltodextrin glucanotransferase from microorganisms belonging to the genus (Bacillus)
lucanotransferase, hereinafter referred to as CGTase. ) Of Bacillus sp. Which carries the genetic information involved in the extracellular production of Bacillus sp. # 1011 bacterium
No. 5) -derived deoxyribonucleic acid (DNA) fragment incorporated into its restriction site.
する特許請求の範囲第1項記載のプラスミド。2. The plasmid according to claim 1, wherein the plasmid is pTUE202.
のDNAであることを特徴とする特許請求の範囲第1項
記載のプラスミド。3. The plasmid according to claim 1, wherein the plasmid vector is DNA of pBR322 plasmid.
ア・コリ(Escherichia coli)であることを特徴とする特
許請求の範囲第1項記載のプラスミド。4. The plasmid according to claim 1, wherein the host belonging to the genus Escherichia is Escherichia coli.
徴とする特許請求の範囲第1項記載のプラスミド。5. The plasmid according to claim 1, wherein the restriction site is a BamHI site.
徴とする特許請求の範囲第1項記載のプラスミド。6. The plasmid according to claim 1, wherein the CGTase is an alkaline CGTase.
細菌に属する微生物であることを特徴とする特許請求の
範囲第1項記載のプラスミド。7. The plasmid according to claim 1, wherein the microorganism belonging to the genus Bacillus is a microorganism belonging to an alkalophilic bacterium.
スsp.#1011菌(微工研菌寄第8685号)であ
ることを特徴とする特許請求の範囲第7項記載のプラス
ミド。8. A microorganism belonging to an alkalophilic bacterium is Bacillus sp. The plasmid according to claim 7, which is a # 1011 bacterium (Ministry of Microbiology, Ltd., No. 8685).
酵素地図を有するバチルスsp.#1011菌(微工研
菌寄第8685号)由来のDNA断片を制限酵素を用い
て調製すること、前記調製されたDNA断片のCGTaseの
菌体外生産に関与する遺伝情報を妨害しない制限酵素を
用いてプラスミドのベクターDNAを制限すること、制
限された前記プラスミドのベクターDNAの制限サイト
に前記DNA断片を組み換えること及び組み換えられた
プラスミドを抽出することからなる、CGTaseの菌体外生
産に関与する遺伝情報を担い、下記の制限酵素地図を有
するバチルスsp.#1011菌由来のDNA断片を組
み込んだプラスミドの構築方法。 9. A Bacillus sp. Which gives the extracellular productivity of CGTase and has the following restriction map. A DNA fragment derived from the # 1011 bacterium (Microtechnology Research Institute No. 8685) is prepared using a restriction enzyme, and a restriction enzyme that does not interfere with genetic information involved in the extracellular production of CGTase of the prepared DNA fragment. For the extracellular production of CGTase, which comprises restricting the vector DNA of a plasmid by using Escherichia coli, recombining the DNA fragment with a restriction site of the vector DNA of the restricted plasmid, and extracting the recombined plasmid. Bacillus sp. Which carries the genetic information involved and has the following restriction map. # 1011 A method for constructing a plasmid incorporating a DNA fragment derived from the bacterium.
ことを特徴とする特許請求の範囲第9項記載のプラスミ
ドの構築方法。10. The method for constructing a plasmid according to claim 9, wherein the plasmid is pTUE202 plasmid.
22プラスミドのDNAを用いることを特徴とする特許請
求の範囲第9項記載のプラスミドの構築方法。11. pBR3 as a plasmid vector DNA
22. The method for constructing a plasmid according to claim 9, wherein the DNA of the plasmid is used.
ことを特徴とする特許請求の範囲第9項記載のプラスミ
ドの構築方法。12. The method for constructing a plasmid according to claim 9, wherein a BamHI site is used as the restriction site.
特徴とする特許請求の範囲第9項記載のプラスミドの構
築方法。13. The method for constructing a plasmid according to claim 9, wherein the CGTase is an alkaline CGTase.
lease)として、Sau3AIを用いることを特徴とする特許請
求の範囲第9項記載のプラスミドの構築方法。14. A restriction enzyme (Endonuc) for preparing a DNA fragment.
10. The method for constructing a plasmid according to claim 9, wherein Sau3AI is used as a lease).
限酵素地図を有するバチルスsp.#1011菌(微工
研菌寄第8685号)由来のDNA断片を、前記細菌の
DNAを制限酵素で分解することにより直接調製するこ
とを特徴とする特許請求の範囲第9項記載のプラスミド
の構築方法。 15. A Bacillus sp. Which gives the extracellular productivity of CGTase and has the following restriction map. The DNA fragment derived from the # 1011 bacterium (Microtechnology Research Institute No. 8685) is directly prepared by decomposing the bacterium's DNA with a restriction enzyme. How to build.
限酵素地図を有するバチルスsp.#1011菌(微工
研菌寄第8685号)由来のDNA断片を、前記細菌の
DNAを制限酵素で分解して得たDNA断片を一旦λD
69バクテリオファージDNAへ組み換えてCGTase生産能
を有する形質導入ファージ粒子を調製した後、そのDN
Aを前記制限酵素で分解することにより調製することを
特徴とする特許請求の範囲第9項記載のプラスミドの構
築方法。 16. A Bacillus sp. Which gives the extracellular productivity of CGTase and has the following restriction map. The DNA fragment derived from the # 1011 bacterium (Microtechnology Research Institute No. 8685) was digested with a restriction enzyme to obtain a DNA fragment with λD.
69 After preparing transducing phage particles capable of producing CGTase by recombination with bacteriophage DNA,
The method for constructing a plasmid according to claim 9, which is prepared by decomposing A with the restriction enzyme.
を担うバチルスsp.#1011菌(微工研菌寄第86
85号)由来のDNA断片を組み込んだ、下記の制限酵
素地図によって特徴づけられるプラスミドpTUE202 を含
有し、CGTaseの菌体外生産能を有するエシェリヒア・コ
リHB101(pTUE 202)[Escherichia coli HB101 (pT
UE 202)]。 17. A Bacillus sp. That carries the genetic information involved in the extracellular production of CGTase. # 1011 bacterium
No. 85) containing a DNA fragment derived from Escherichia coli HB101 (pTUE 202) [Escherichia coli HB101 (pTUE 202) containing a plasmid pTUE202 characterized by the following restriction enzyme map and capable of producing CGTase in vitro.
UE 202)].
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5097286A JPH0640826B2 (en) | 1986-03-08 | 1986-03-08 | Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5097286A JPH0640826B2 (en) | 1986-03-08 | 1986-03-08 | Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62208286A JPS62208286A (en) | 1987-09-12 |
| JPH0640826B2 true JPH0640826B2 (en) | 1994-06-01 |
Family
ID=12873726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5097286A Expired - Lifetime JPH0640826B2 (en) | 1986-03-08 | 1986-03-08 | Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0640826B2 (en) |
-
1986
- 1986-03-08 JP JP5097286A patent/JPH0640826B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62208286A (en) | 1987-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3086249B2 (en) | Mutant α-amylase derived from bacteria having high heat, acid and / or alkali stability | |
| Cornet et al. | Characterization of two cel (cellulose degradation) genes of Clostridium thermocellum coding for endoglucanases | |
| JPH04507346A (en) | Alkaline proteolytic enzyme and its production method | |
| HU195533B (en) | Process for producing microorganisms modificated with genetical engineering for producing amilase | |
| JPH04228071A (en) | Amylase a-180 for producing maltopentaose, method of production thereof, dna structure and alkalophilic isolation body | |
| JPH0630575B2 (en) | γ-CGase | |
| JPH08298988A (en) | Alkaline pullulanase gene having alkaline α-amylase activity | |
| JPH0640826B2 (en) | Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid | |
| JP2612687B2 (en) | Polypeptide having cyclomaltodextrin glucanotransferase activity | |
| JPH05244945A (en) | Method for producing α-cyclodextrin | |
| JP2612684B2 (en) | Transformed microorganism into which recombinant DNA containing cyclomaltodextrin glucanotransferase gene has been introduced and its use | |
| JP4372986B2 (en) | Alkaline pullulanase | |
| CA1335183C (en) | Polypeptide possessing cyclomaltodextrin glucanotransferase activity | |
| JPH0223872A (en) | Recombinant plasmid, bacillus subtilis transformed with said plasmid and production of heat-resistant pullulanase using same | |
| JPH0640827B2 (en) | Novel plasmid, method for constructing the same, and novel microorganism containing the plasmid | |
| JP2830030B2 (en) | DNA having genetic information of thermostable peroxidase and use thereof | |
| JP2833793B2 (en) | Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase | |
| JP2567199B2 (en) | Bacillus subtilis and method of forming the same | |
| JP2671008B2 (en) | DNA encoding cyclomaltodextrin glucenotransferase, recombinant plasmid containing the same, and transformed microorganism containing the plasmid | |
| JPH0353883A (en) | Heat-resistant beta-1,3-glucanase gene dna, recombinant plasmid and transformant containing the dna, heat-resistant beta-1,3-glucanase and production thereof | |
| JP2544177B2 (en) | DNA fragment containing the cellulase gene | |
| JP2814177B2 (en) | DNA fragment containing alkaline pullulanase gene, vector incorporating the DNA fragment, and microorganism having the vector | |
| JPH0714346B2 (en) | Genes involved in maltooligosaccharide production, corresponding recombinant plasmids and recombinant microorganisms | |
| JPH0427392A (en) | G6 amylase gene | |
| WO1994019468A1 (en) | Dna fragment containing gene for alkaline pullulanase |